Exploring What are the new drug modalities 2025?: An Evolving Pharmaceutical Landscape
•
4 min read
According to a Boston Consulting Group report, the projected pipeline value for new modalities has grown significantly in 2025, driven by advances in antibodies, proteins, and nucleic acids. This acceleration marks a pivotal shift in **what are the new drug modalities 2025** and how they are changing the face of pharmaceutical development.
